Glycated Hemoglobin A
"Glycated Hemoglobin A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN A, occurring as a minor fraction of the hemoglobin components of human erythrocytes. Hemoglobin A1c is hemoglobin A with glucose covalently bound to the terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes.
Descriptor ID |
D006442
|
MeSH Number(s) |
D09.400.430.937 D12.776.124.400.405.440 D12.776.395.381 D12.776.422.316.762.380.440
|
Concept/Terms |
Glycated Hemoglobin A- Glycated Hemoglobin A
- Hemoglobin A, Glycated
- Hb A1a+b
- Hb A1c
- HbA1
- Glycosylated Hemoglobin A
- Hemoglobin A, Glycosylated
- Hb A1
- Glycohemoglobin A
- Hemoglobin A(1)
Hb A1a-2- Hb A1a-2
- Hemoglobin, Glycated A1a-2
- A1a-2 Hemoglobin, Glycated
- Glycated A1a-2 Hemoglobin
- Hemoglobin, Glycated A1a 2
Hemoglobin, Glycosylated A1a-1- Hemoglobin, Glycosylated A1a-1
- A1a-1 Hemoglobin, Glycosylated
- Glycosylated A1a-1 Hemoglobin
- Hemoglobin, Glycosylated A1a 1
- Hb A1a-1
Hemoglobin, Glycated A1b- Hemoglobin, Glycated A1b
- A1b Hemoglobin, Glycated
- Glycated A1b Hemoglobin
- Hb A1b
- Hemoglobin, Glycosylated A1b
- A1b Hemoglobin, Glycosylated
- Glycosylated A1b Hemoglobin
Glycated Hemoglobin A1c- Glycated Hemoglobin A1c
- Hemoglobin A1c, Glycated
- Glycosylated Hemoglobin A1c
- Hemoglobin A1c, Glycosylated
Glycated Hemoglobins- Glycated Hemoglobins
- Hemoglobins, Glycated
- Hemoglobin, Glycosylated
- Glycosylated Hemoglobin
|
Below are MeSH descriptors whose meaning is more general than "Glycated Hemoglobin A".
Below are MeSH descriptors whose meaning is more specific than "Glycated Hemoglobin A".
This graph shows the total number of publications written about "Glycated Hemoglobin A" by people in this website by year, and whether "Glycated Hemoglobin A" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 0 | 1 | 1 | 1994 | 0 | 1 | 1 | 1995 | 0 | 3 | 3 | 1996 | 0 | 2 | 2 | 1998 | 1 | 1 | 2 | 1999 | 0 | 2 | 2 | 2000 | 1 | 1 | 2 | 2001 | 1 | 0 | 1 | 2002 | 2 | 2 | 4 | 2003 | 0 | 6 | 6 | 2004 | 2 | 6 | 8 | 2005 | 0 | 8 | 8 | 2006 | 5 | 4 | 9 | 2007 | 3 | 8 | 11 | 2008 | 3 | 13 | 16 | 2009 | 4 | 17 | 21 | 2010 | 2 | 9 | 11 | 2011 | 4 | 11 | 15 | 2012 | 6 | 12 | 18 | 2013 | 6 | 17 | 23 | 2014 | 8 | 19 | 27 | 2015 | 6 | 15 | 21 | 2016 | 3 | 16 | 19 | 2017 | 10 | 37 | 47 | 2018 | 6 | 27 | 33 | 2019 | 10 | 30 | 40 | 2020 | 10 | 30 | 40 | 2021 | 3 | 27 | 30 | 2022 | 0 | 26 | 26 |
To return to the timeline, click here.
Below are the most recent publications written about "Glycated Hemoglobin A" by people in Profiles.
-
Perreault L, Davies M, Frias JP, Laursen PN, Lingvay I, Machineni S, Varbo A, Wilding JPH, Wallenstein SOR, le Roux CW. Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program. Diabetes Care. 2022 10 01; 45(10):2396-2405.
-
Messer LH, Buckingham BA, Cogen F, Daniels M, Forlenza G, Jafri RZ, Mauras N, Muir A, Wadwa RP, White PC, Russell SJ, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Marak MC, Calhoun P, Beck RW. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. Diabetes Technol Ther. 2022 10; 24(10):712-725.
-
Russell SJ, Beck RW, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Calhoun P, Wadwa RP, Buckingham B, Zhou K, Daniels M, Raskin P, White PC, Lynch J, Pettus J, Hirsch IB, Goland R, Buse JB, Kruger D, Mauras N, Muir A, McGill JB, Cogen F, Weissberg-Benchell J, Sherwood JS, Castellanos LE, Hillard MA, Tuffaha M, Putman MS, Sands MY, Forlenza G, Slover R, Messer LH, Cobry E, Shah VN, Polsky S, Lal R, Ekhlaspour L, Hughes MS, Basina M, Hatipoglu B, Olansky L, Bhangoo A, Forghani N, Kashmiri H, Sutton F, Choudhary A, Penn J, Jafri R, Rayas M, Escaname E, Kerr C, Favela-Prezas R, Boeder S, Trikudanathan S, Williams KM, Leibel N, Kirkman MS, Bergamo K, Klein KR, Dostou JM, Machineni S, Young LA, Diner JC, Bhan A, Jones JK, Benson M, Bird K, Englert K, Permuy J, Cossen K, Felner E, Salam M, Silverstein JM, Adamson S, Cedeno A, Meighan S, Dauber A. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. 2022 09 29; 387(13):1161-1172.
-
Sherr JL, Bode BW, Forlenza GP, Laffel LM, Schoelwer MJ, Buckingham BA, Criego AB, DeSalvo DJ, MacLeish SA, Hansen DW, Ly TT, Sherr JL, Weyman K, Tichy E, VanName M, Brei M, Zgorski M, Steffen A, Carria L, Bode BW, Busby A, Forlenza GP, Wadwa RP, Slover R, Cobry E, Messer L, Laffel LM, Isganaitis E, Ambler-Osborn L, Freiner E, Turcotte C, Volkening L, Schoelwer M, Brown SA, Krauthause K, Emory E, Oliveri M, Buckingham BA, Ekhlaspour L, Kingman R, Criego AB, Schwartz BL, Gandrud LM, Grieme A, Hyatt J, DeSalvo DJ, McKay S, DeLaO K, Villegas C, MacLeish SA, Wood JR, Kaminski BA, Casey T, Campbell W, Behm K, Adams R, Hansen DW, Stone SL, Bzdick S, Bulger J, Agostini L, Doolittle S, Kivilaid K, Kleve K, Ly TT, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E. Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial. Diabetes Care. 2022 08 01; 45(8):1907-1910.
-
Messer LH, Vigers T, Pyle L, Fivekiller E, Wadwa RP, Hernandez TL, Cook PF. Novel predictors of daily fluctuations in glycemia and self-management in adolescents and young adults with type 1 diabetes. Diabet Med. 2022 09; 39(9):e14910.
-
Canonico ME, Hsia J, Guthrie NL, Simmons M, Mehta P, Lupinacci P, Edwards K, Mosesso K, Gearhart M, Skuban A, Bonaca MP, Berman MA. Cognitive behavioral therapy delivered via digital mobile application for the treatment of type 2 diabetes: Rationale, design, and baseline characteristics of a randomized, controlled trial. Clin Cardiol. 2022 Aug; 45(8):850-856.
-
Akturk HK, Snell-Bergeon J, Shah VN. Efficacy and Safety of Tandem Control IQ Without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes. Diabetes Technol Ther. 2022 10; 24(10):779-783.
-
Akturk HK, Herrero P, Oliver N, Wise H, Eikermann E, Snell-Bergeon J, Shah VN. Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration. Diabetes Technol Ther. 2022 10; 24(10):749-753.
-
Basu A, Alman AC, Snell-Bergeon JK. Associations of Dietary Antioxidants with Glycated Hemoglobin and Insulin Sensitivity in Adults with and without Type 1 Diabetes. J Diabetes Res. 2022; 2022:4747573.
-
Johnson SB, Tamura R, McIver KL, Pate RR, Driscoll KA, Melin J, Larsson HE, Haller MJ, Yang J. The association of physical activity to oral glucose tolerance test outcomes in multiple autoantibody positive children: The TEDDY Study. Pediatr Diabetes. 2022 11; 23(7):1017-1026.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|